Home > PE Ratio > GENNEX LABORATORIES

GENNEX LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENNEX LABORATORIES is 24.61.

Share Price ₹18.7Jan 03,2025
Market Cap ₹425.5 Cr
Earnings-TTM₹17.3 CrTTM-Consolidated Results
Price/Earnings24.61xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results
GENNEX LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENNEX LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENNEX LABORATORIES is calculated as :

Current Market Cap [ ₹425.5 Cr] as on Jan 03,2025

(/) Earnings [ ₹17.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 24.61x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENNEX LABORATORIES , the investors are currently willing to pay 24.61 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENNEX LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENNEX LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of GENNEX LABORATORIES


PE Ratio Performance Analysis for GENNEX LABORATORIES

- GENNEX LABORATORIES 's latest p/e ratio is 24.61x.

- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.71x.

- GENNEX LABORATORIES 's operated at median p/e ratio of 16x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 31.6x.

- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 11.69x.


How does GENNEX LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENNEX LABORATORIES 17.2924.61425.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.84443,661.0
CIPLA LTD4,485.2227.19121,970.0
DR REDDYS LABORATORIES LTD5,406.8020.88112,877.0
ZYDUS LIFESCIENCES LTD4,298.9022.8398,163.2
DIVIS LABORATORIES LTD1,836.0087.42160,496.0
MANKIND PHARMA LTD2,124.8657.05121,222.0
TORRENT PHARMACEUTICALS LTD1,802.0063.86115,071.0
LUPIN LTD2,651.9440.74108,030.0
AUROBINDO PHARMA LTD3,598.8321.2976,628.1
ABBOTT INDIA LTD1,284.6648.7562,629.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GENNEX LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.88x
Max industry PE 87.42x
Median industry PE 39.84x
Average industry PE 41.31x



You may also like the below Video Courses